Skip to main content

Table 4 Differences of various biomarkers in subjects with and without metabolic syndrome as per IDF criteria

From: Metabolic clustering of risk factors: evaluation of Triglyceride-glucose index (TyG index) for evaluation of insulin resistance

Parameter

Metabolic syndrome

N

Mean

Std. dev

Sig. (2-tailed)

Fasting plasma glucose (mmol/L)

Present

117

5.72

1.85

0.070

Absent

108

5.25

1.98

Fasting triglyceride (mmol/L)

Present

117

1.79

0.68

< 0.001

Absent

108

1.37

0.68

Triglyceride-glucose index (TyG)

Present

117

8.91

0.42

< 0.001

Absent

108

8.53

0.55

HDLc (mmol/L)

Present

117

0.94

0.25

0.040

Absent

108

1.02

0.26

Non-HDLc (mmol/L)

Present

117

3.61

0.60

0.004

Absent

108

3.36

0.65

sdLDLc (mmol/L)

Present

117

0.92

0.33

< 0.001

Absent

108

0.70

0.29

HbA1c (%)

Present

115

5.93

0.94

0.001

Absent

107

5.51

0.88

HOMAIR

Present

115

2.53

1.77

0.084

Absent

107

2.10

1.89